Literature DB >> 20471394

Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.

Konstantin S Mineev1, Eduard V Bocharov, Yulia E Pustovalova, Olga V Bocharova, Vladimir V Chupin, Alexander S Arseniev.   

Abstract

Growth factor receptor tyrosine kinases of the ErbB family play a significant role in vital cellular processes and various cancers. During signal transduction across plasma membrane, ErbB receptors are involved in lateral homodimerization and heterodimerization with proper assembly of their extracellular single-span transmembrane (TM) and cytoplasmic domains. The ErbB1/ErbB2 heterodimer appears to be the strongest and most potent inducer of cellular transformation and mitogenic signaling compared to other ErbB homodimers and heterodimers. Spatial structure of the heterodimeric complex formed by TM domains of ErbB1 and ErbB2 receptors embedded into lipid bicelles was obtained by solution NMR. The ErbB1 and ErbB2 TM domains associate in a right-handed alpha-helical bundle through their N-terminal double GG4-like motif T(648)G(649)X(2)G(652)A(653) and glycine zipper motif T(652)X(3)S(656)X(3)G(660), respectively. The described heterodimer conformation is believed to support the juxtamembrane and kinase domain configuration corresponding to the receptor active state. The capability for multiple polar interactions, along with hydrogen bonding between TM segments, correlates with the observed highest affinity of the ErbB1/ErbB2 heterodimer, implying an important contribution of the TM helix-helix interaction to signal transduction. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471394     DOI: 10.1016/j.jmb.2010.05.016

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  50 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

2.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

3.  Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR.

Authors:  Julie K L Sinclair; Allison S Walker; Amy E Doerner; Alanna Schepartz
Journal:  Cell Chem Biol       Date:  2018-05-03       Impact factor: 8.116

4.  Evolution of the genetic code by incorporation of amino acids that improved or changed protein function.

Authors:  Brian R Francis
Journal:  J Mol Evol       Date:  2013-06-07       Impact factor: 2.395

Review 5.  Design of self-assembling transmembrane helical bundles to elucidate principles required for membrane protein folding and ion transport.

Authors:  Nathan H Joh; Gevorg Grigoryan; Yibing Wu; William F DeGrado
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

6.  Production of disulfide-stabilized transmembrane peptide complexes for structural studies.

Authors:  Pooja Sharma; Mariam Kaywan-Lutfi; Logesvaran Krshnan; Eamon F X Byrne; Melissa Joy Call; Matthew Edwin Call
Journal:  J Vis Exp       Date:  2013-03-06       Impact factor: 1.355

7.  Evolutionary-guided de novo structure prediction of self-associated transmembrane helical proteins with near-atomic accuracy.

Authors:  Y Wang; P Barth
Journal:  Nat Commun       Date:  2015-05-21       Impact factor: 14.919

8.  Exploring the dynamics and interaction of a full ErbB2 receptor and Trastuzumab-Fab antibody in a lipid bilayer model using Martini coarse-grained force field.

Authors:  Juan Felipe Franco-Gonzalez; Javier Ramos; Victor L Cruz; Javier Martinez-Salazar
Journal:  J Comput Aided Mol Des       Date:  2014-08-17       Impact factor: 3.686

9.  Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.

Authors:  Hiromasa Yamamoto; Shinichi Toyooka; Takashi Ninomiya; Shigemi Matsumoto; Masashi Kanai; Shuta Tomida; Katsuyuki Kiura; Manabu Muto; Ken Suzawa; Patrice Desmeules; Mark G Kris; Bob T Li; Marc Ladanyi
Journal:  Oncologist       Date:  2017-11-16

Review 10.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.